Regulations.gov document
Considerations in Demonstrating Interchangeability With a Reference Product; Draft…
Notice · FDA-2017-D-0154 · posted Jan 18, 2017
Key facts
| Document ID | FDA-2017-D-0154-0001 |
|---|---|
| Title | Considerations in Demonstrating Interchangeability With a Reference Product; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2017-D-0154 |
| Posted | Jan 18, 2017 |
| Federal Register citation | 82 FR 5579 |
| FR document number | 2017-01042 |
| Comment period opens | Jan 18, 2017 |
| Comments due | Mar 21, 2017 |
| Effective date | Jan 18, 2017 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: